Infusion Lifting Face Cream for Wrinkle Fillers 45+, 50 ml
Discover the secret to smooth and supple skin after 45! At this age, the skin's needs significantly increase. Its firmness decreases, facial features lose definition, and wrinkles deepen. That's why it's worth choosing a good cream whose effects are similar to a volumetric facelift treatment. The Pour La Beauté series features revolutionary 4D dermofusion technology. It utilizes an infusion mechanism to transport active ingredients using the latest generation of microtransmitters, called cell transition promoters, which enable precise transfer of active ingredients to the deep layers of the skin and their sequential, gradual release. The intensified four-stage anti-aging action occurs at several levels of the skin: Corneo-Fusion – thanks to its biomimetic formula, the cream's ingredients easily penetrate the outer barrier of the epidermis, simultaneously exerting a powerful repairing effect on its surface. In-Fusion – active substances synchronously penetrate subsequent layers of the epidermis. Diffusion – the even distribution of ingredients in targeted skin structures activates the process of intensive regeneration and precise wrinkle filling. Endofusion – a stage of radical improvement in skin firmness and tone from within. The advanced dermoformula guarantees a multidimensional modeling and filling effect, comparable to a professional volumetric facelift treatment, restoring volume and firmness to the facial skin. Exclusive black rose extract actively protects the skin from free radicals and smooths it. Pure retinol reactivates repair processes, radically renewing collagen structures. MATRIXYL®3000 stimulates the synthesis of skin matrix components, filling wrinkles and improving its density. 24k gold particles provide a powerful lifting effect from the very first application. Results confirmed by research*:98% noticeable improvement in skin elasticity and firmness, 92% visible wrinkle smoothing, 98% firming and improved skin tone. *Studies on a selected group of women over a 4-week period. Dermatologically tested.
Comment